Meeder Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.9K | Hold |
|
|||||
|
2025
Q2 | $24.9K | Buy |
|
|||||
|
2025
Q1 | $22.8K | Sell |
|
|||||
|
2024
Q4 | $29.4K | Buy |
|
|||||
|
2024
Q3 | $33K | Buy |
|
|||||
|
2024
Q2 | $31.9K | Sell |
|
|||||
|
2024
Q1 | $247K | Buy |
|
|||||
|
2023
Q4 | $212K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $3.8M | Buy |
|
|||||
|
2023
Q1 | $3.18M | Buy |
|
|||||
|
2022
Q4 | $2.7M | Sell |
|
|||||
|
2022
Q3 | $4.34M | Buy |
|
|||||
|
2022
Q2 | $2.69M | Buy |
|
|||||
|
2022
Q1 | $1.05M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.07M | Buy |
|
|||||
|
2021
Q2 | $368K | Sell |
|
|||||
|
2021
Q1 | $3.39M | Buy |
|
|||||
|
2020
Q4 | $367K | Sell |
|
|||||
|
2020
Q3 | $4.8M | Buy |
|
|||||
|
2020
Q2 | $5.04M | Buy |
|
|||||
|
2020
Q1 | $3.91M | Sell |
|
|||||
|
2019
Q4 | $9.86M | Sell |
|
|||||
|
2019
Q3 | $7.79M | Buy |
|
|||||
|
2019
Q2 | $8.26M | Buy |
|
|||||
|
2019
Q1 | $7.45M | Buy |
|
|||||
|
2018
Q4 | $5.87M | Buy |
|
|||||
|
2018
Q3 | $5.64M | Sell |
|
|||||
|
2018
Q2 | $5.01M | Buy |
|
|||||
|
2018
Q1 | $3.31M | Buy |
|
|||||
|
2017
Q4 | $1.68M | Sell |
|
|||||
|
2017
Q3 | $1.9M | Buy |
|
|||||
|
2017
Q2 | $1.5M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $107K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.79M | Buy |
|